9 insiders reported 18 Form 4 transactions for Coeptis Therapeutics Holdings, Inc. (COEP) over the past 18 months (most recent 2026-02-13). Recent activity: Cochran Christopher P. (Director) Buy 5,700 shares, Cochran Christopher P. (Director) Buy 3,250 shares, Cogley Brian (Chief Financial Officer) Buy 10,000 shares, Cogley Brian (Chief Financial Officer) Buy 12,500 shares, Sheehy Christine Elise (VP Compliance and Secy) Buy 1,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-13 | Cochran Christopher P. | Director | Buy | 5,700 | $60,192 |
| 2026-02-13 | Cochran Christopher P. | Director | Buy | 3,250 | $0 |
| 2026-02-13 | Cogley Brian | Chief Financial Officer | Buy | 10,000 | $105,600 |
| 2026-02-13 | Cogley Brian | Chief Financial Officer | Buy | 12,500 | $0 |
| 2026-02-13 | Sheehy Christine Elise | VP Compliance and Secy | Buy | 1,000 | $10,560 |
| 2026-02-13 | Sheehy Christine Elise | VP Compliance and Secy | Buy | 12,500 | $0 |
| 2026-02-13 | Mehalick David | CEO and President | Buy | 148,875 | $1.0M |
| 2026-02-13 | Mehalick David | CEO and President | Buy | 51,250 | $0 |
| 2026-02-13 | Yerace Daniel Alexander | VP Operations | Buy | 10,000 | $104,100 |
| 2026-02-13 | Yerace Daniel Alexander | VP Operations | Buy | 20,000 | $0 |
| 2026-02-13 | Deschamps Philippe | Director | Buy | 5,700 | $60,192 |
| 2026-02-13 | Deschamps Philippe | Director | Buy | 3,250 | $0 |
| 2026-02-13 | Calise Chris | Director | Buy | 5,700 | $60,192 |
| 2026-02-13 | Calise Chris | Director | Buy | 3,250 | $0 |
| 2026-02-13 | Salkind Gene | Director | Buy | 5,700 | $60,192 |
| 2026-02-13 | Salkind Gene | Director | Buy | 3,250 | $0 |
| 2026-02-13 | DeSilva Tara | Director | Buy | 5,700 | $60,192 |
| 2026-02-13 | DeSilva Tara | Director | Buy | 3,250 | $0 |
Source: SEC Form 4 filings · as of 2026-02-13